Revvity Inc (RVTY)
102.60
+0.13
(+0.13%)
USD |
NYSE |
May 01, 16:00
102.53
-0.07
(-0.07%)
Pre-Market: 20:00
Revvity Price to Book Value: 1.615 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 1.615 |
| April 30, 2024 | 1.613 |
| April 29, 2024 | 1.653 |
| April 26, 2024 | 1.598 |
| April 25, 2024 | 1.607 |
| April 24, 2024 | 1.616 |
| April 23, 2024 | 1.629 |
| April 22, 2024 | 1.586 |
| April 19, 2024 | 1.588 |
| April 18, 2024 | 1.564 |
| April 17, 2024 | 1.583 |
| April 16, 2024 | 1.579 |
| April 15, 2024 | 1.611 |
| April 12, 2024 | 1.629 |
| April 11, 2024 | 1.708 |
| April 10, 2024 | 1.699 |
| April 09, 2024 | 1.743 |
| April 08, 2024 | 1.675 |
| April 05, 2024 | 1.610 |
| April 04, 2024 | 1.601 |
| April 03, 2024 | 1.611 |
| April 02, 2024 | 1.609 |
| April 01, 2024 | 1.626 |
| March 31, 2024 | |
| March 28, 2024 | 1.648 |
| Date | Value |
|---|---|
| March 27, 2024 | 1.654 |
| March 26, 2024 | 1.623 |
| March 25, 2024 | 1.616 |
| March 22, 2024 | 1.62 |
| March 21, 2024 | 1.649 |
| March 20, 2024 | 1.642 |
| March 19, 2024 | 1.636 |
| March 18, 2024 | 1.634 |
| March 15, 2024 | 1.646 |
| March 14, 2024 | 1.646 |
| March 13, 2024 | 1.694 |
| March 12, 2024 | 1.707 |
| March 11, 2024 | 1.714 |
| March 08, 2024 | 1.715 |
| March 07, 2024 | 1.702 |
| March 06, 2024 | 1.684 |
| March 05, 2024 | 1.679 |
| March 04, 2024 | 1.702 |
| March 01, 2024 | 1.681 |
| February 29, 2024 | 1.720 |
| February 28, 2024 | 1.684 |
| February 27, 2024 | 1.657 |
| February 26, 2024 | 1.631 |
| February 23, 2024 | 1.639 |
| February 22, 2024 | 1.636 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.316
Minimum
Oct 30 2023
5.582
Maximum
Sep 17 2021
3.125
Average
3.222
Median
Mar 18 2022
Price to Book Value Benchmarks
| Agilent Technologies Inc | 6.568 |
| Bruker Corp | 7.891 |
| Azenta Inc | 1.189 |
| Harvard Bioscience Inc | 2.269 |
| Bionano Genomics Inc | 0.6104 |
Price to Book Value Related Metrics
| PE Ratio | 85.04 |
| PS Ratio | 4.672 |
| Price to Free Cash Flow | 131.14 |
| Price | 102.60 |
| Earnings Yield | 1.18% |
| Market Cap | 12.67B |
| Operating PE Ratio | 47.03 |
| Normalized PE Ratio | 58.68 |